quinuclidines has been researched along with Cancer of Head in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbe, AG | 1 |
| Hang, W; Jian, YP; Li, DD; Li, YL; Liu, G; Quan, CS; Shen, XF; Sun, QH; Wang, YS; Xu, ZX; Yin, ZX; Zeng, Q; Zhang, YH; Zhao, RX | 1 |
| Forbes, B; Garcia, CMA; Malallah, OS; Proctor, GB; Royall, PG | 1 |
| Endo, M; Katsube, Y; Motohashi, R; Nakamura, K; Sato, H; Suzuki, M; Tsukahara, K; Ueda, Y | 1 |
| Califano, JA; Kang, SK; Koch, WM; Minn, I; Roh, JL; Sidransky, D | 1 |
| Atri, R; Bhutani, G; Dhankar, R; Gupta, MC; Kaushal, J; Kaushal, V; Verma, S | 1 |
| Chambers, MS; Stinnett, S; Witsell, DL | 1 |
| Bruce, SD | 1 |
| Aframian, DJ; Nahlieli, O; Palmon, A | 1 |
| Johnstone, PA; Kahn, ST | 1 |
| Urba, S | 1 |
| Armstrong, I; Biel, MA; Chambers, MS; Hodge, KM; Jones, CU; Posner, M; Vitti, R; Weber, RS; Yen, C | 1 |
| Armstrong, I; Biel, MA; Chambers, MS; Chen, Y; Garden, AS; Haddad, R; Hodge, KM; Holland, JM; Jones, CU; Ship, JA; Vitti, R; Weber, RS | 1 |
4 review(s) available for quinuclidines and Cancer of Head
| Article | Year |
|---|---|
Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
Topics: Drug Delivery Systems; Head and Neck Neoplasms; Humans; Mouth Mucosa; Muscarinic Agonists; Pilocarpine; Quinuclidines; Radiation Injuries; Saliva; Thiophenes; Time Factors; Xerostomia | 2018 |
Radiation-induced xerostomia: how dry is your patient?
Topics: Acupuncture Therapy; Head and Neck Neoplasms; Humans; Muscarinic Agonists; Nurse's Role; Nursing Assessment; Oncology Nursing; Oral Hygiene; Pilocarpine; Quality of Life; Quinuclidines; Radiotherapy; Radiotherapy Dosage; Salivation; Thiophenes; Xerostomia | 2004 |
Management of xerostomia related to radiotherapy for head and neck cancer.
Topics: Acupuncture Therapy; Amifostine; Clinical Trials as Topic; Head and Neck Neoplasms; Humans; Muscarinic Agonists; Palliative Care; Pilocarpine; Quinuclidines; Radiation-Protective Agents; Radiotherapy; Submandibular Gland; Thiophenes; Xerostomia | 2005 |
Radiation-induced nausea and vomiting.
Topics: Abdominal Neoplasms; Dexamethasone; Dose Fractionation, Radiation; Head and Neck Neoplasms; Humans; Isoquinolines; Nausea; Palonosetron; Practice Guidelines as Topic; Quinuclidines; Radiotherapy; Serotonin Antagonists; Thoracic Neoplasms; Vomiting | 2007 |
4 trial(s) available for quinuclidines and Cancer of Head
| Article | Year |
|---|---|
Antiemetic therapy of fosaprepitant, palonosetron, and dexamethasone combined with cisplatin-based chemotherapy for head and neck carcinomas.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Carcinoma; Cisplatin; Dexamethasone; Drug Therapy, Combination; Eating; Female; Head and Neck Neoplasms; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Neurokinin-1 Receptor Antagonists; Palonosetron; Quinuclidines; Serotonin Antagonists | 2014 |
Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancer.
Topics: Acute Disease; Adult; Antiemetics; Antineoplastic Agents; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Isoquinolines; Male; Middle Aged; Nausea; Ondansetron; Palonosetron; Quinuclidines; Serotonin Antagonists; Time Factors; Vomiting | 2010 |
Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.
Topics: Carcinoma, Squamous Cell; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Muscarinic Agonists; Oral Health; Quality of Life; Quinuclidines; Radiotherapy; Salivary Glands; Severity of Illness Index; Thiophenes; Xerostomia | 2012 |
Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
Topics: Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Muscarinic Antagonists; Quinuclidines; Salivation; Thiophenes; Xerostomia | 2007 |
5 other study(ies) available for quinuclidines and Cancer of Head
| Article | Year |
|---|---|
Long-term Use of the Sialogogue Medications Pilocarpine and Cevimeline Can Reduce Xerostomia Symptoms and Increase Salivary Flow in Head and Neck Cancer Survivors After Radiotherapy.
Topics: Head and Neck Neoplasms; Humans; Pilocarpine; Quinuclidines; Survivors; Thiophenes; Xerostomia | 2017 |
Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Dioxolanes; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Head and Neck Neoplasms; Humans; Male; Mice; Mice, SCID; Prognosis; Quinuclidines; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Drug Screening Assays, Antitumor; Female; Furans; Genetic Therapy; Head and Neck Neoplasms; Humans; Imidazoles; Male; Piperazines; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53 | 2011 |
[Future therapy strategies for salivary gland impairment].
Topics: Amifostine; Cranial Irradiation; Head and Neck Neoplasms; Humans; Muscarinic Agonists; Pilocarpine; Quinuclidines; Radiation Injuries; Radiation-Protective Agents; Regeneration; Saliva; Salivary Glands; Thiophenes | 2004 |
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
Topics: Adult; Aged; Aged, 80 and over; Diarrhea; Dyspepsia; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Muscarinic Agonists; Nausea; Quinuclidines; Radiotherapy Dosage; Sweat; Thiophenes; Xerostomia | 2007 |